Back


08/02/2017
Zealand reports Q4 2016 Lyxumia® royalty revenue
Zealand receives royalty revenue of DKK 5.3 million / €0.7 million in Q4 2016 (and DKK 24.4 million / €3.3 million in full year 2016) from sales of Lyxumia® by Sanofi outside the United States. [...]

Download the pdf file





X

X